How Dr. Scott Rocklage Is An Ideal Investor In The Biotechnology Industry

9 out of 10 drugs under development are never released to the public because they’re either ineffective or too dangerous to use. It takes someone very experienced in the industry in order to successfully invest in the biotechnology industry due to this, especially when it comes to startups.

Dr. Scott Rocklage is someone that fits the bill as he has extensive experience in the industry both as a top executive and as a researcher. He is now the managing partner of 5 AM Ventures LLC which specializes in investing in new biotechnology firms.

Dr. Scott Rocklage earned his undergraduate degree in chemistry at the University of California. He then attended the Massachusetts Institute of Technology so that he could earn a Ph.D. in this subject.

He says that while attending MIT he did his research in Professor Richard Schrock’s laboratory, a man who went on to earn a Nobel Prize in Chemistry. Learn more about Scott Rocklage: and

After graduating from college, Dr. Scott Rocklage launched his career as a researcher. He worked for two companies in this position, Catalytica and Salutar. He was very successful and proved to be a good leader.

Eventually, his leadership abilities landed him a job as an executive in the biotechnology industry. He served as an executive for a number of companies.

One of them was Nycomed Salutar where he was eventually named as the president and chief executive officer of the firm. He was also at one time the Chairman and CEO of Cubist Pharmaceuticals (which was bought a number of years ago by Merck). Read more: Scott Rocklage | Ideamesch and Scott Rocklage | Crunchbase

Based in Boston, Massachusetts, Dr. Scott Rocklage has now invested in many companies in the biotechnology industry. Under his leadership 5 AM Ventures doesn’t just invest in companies, however. Instead, they become involved in the management of the company. Thi includes being on the board of these firms.

He is the board chairman for three companies at the present time; Kinestral, Rennovia, and Cidara. He serves on the board of two other companies as well; Pulmatrix and Epirus.

Dr. Scott Rocklage says that he works with entrepreneurs as a career. This can include those who are physicians, scientists, or general business.

He says that his role in working with entrepreneurs is to help them form their ideas into something that can be brought to the market. In doing so he helps people have drugs that will help with their unmet medical needs.